Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$158M |
| 2 |
Match Group
MTCH
|
+$112M |
| 3 |
Algonquin Power & Utilities
AQN
|
+$62M |
| 4 |
Adobe
ADBE
|
+$51M |
| 5 |
KKR & Co
KKR
|
+$46.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$486M |
| 2 |
PPLI
People Inc
PPLI
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$110M |
| 4 |
Alibaba
BABA
|
+$109M |
| 5 |
Fastly Inc
FSLY
|
+$85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Healthcare | 12.99% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Financials | 12.09% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
CarGurus
CARG
$3.47B
| $1.16M | ﹤0.01% |
53,587
+6,579
| +14% | +$168K |
|
1977
Liberty Latin America Class C
LILAK
$1.64B
| $1.15M | ﹤0.01% |
155,766
+33,276
| +27% | +$267K |
|
|
TLND
1978
DELISTED
Talend S.A. American Depositary Shares
TLND
| $1.15M | ﹤0.01% |
29,485
+6,565
| +29% | +$254K |
|
|
DCPH
1979
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.15M | ﹤0.01% |
22,397
-1,645
| -7% | -$80.6K |
|
1980
Workiva
WK
$3.54B
| $1.15M | ﹤0.01% |
20,590
-1,128
| -5% | -$62.8K |
|
|
ARGO
1981
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $1.15M | ﹤0.01% |
33,296
+644
| +2% | +$22.5K |
|
1982
Stellus Capital Investment Corp
SCM
$243M
| $1.14M | ﹤0.01% |
131,008
+4,093
| +3% | +$33.3K |
|
1983
Cerence
CRNC
$413M
| $1.14M | ﹤0.01% |
23,320
-3,415
| -13% | -$164K |
|
|
BKCC
1984
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $1.14M | ﹤0.01% |
464,061
+35,529
| +8% | +$93.7K |
|
1985
Axsome Therapeutics
AXSM
$10.9B
| $1.14M | ﹤0.01% |
15,964
-1,220
| -7% | -$95.1K |
|
1986
Arlo Technologies
ARLO
$1.65B
| $1.13M | ﹤0.01% |
214,427
+2,175
| +1% | +$10.5K |
|
1987
Inovio Pharmaceuticals
INO
$69M
| $1.12M | ﹤0.01% |
8,057
+4,408
| +121% | +$919K |
|
1988
WisdomTree
WT
$3.22B
| $1.12M | ﹤0.01% |
349,535
-16,129
| -4% | -$58.2K |
|
1989
Universal Insurance Holdings
UVE
$1.23B
| $1.12M | ﹤0.01% |
80,759
-1,930
| -2% | -$34.1K |
|
1990
Moelis & Co
MC
$4.94B
| $1.12M | ﹤0.01% |
31,787
+1,826
| +6% | +$57.7K |
|
|
LGF.B
1991
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $1.12M | ﹤0.01% |
128,093
+26,674
| +26% | +$213K |
|
1992
Royalty Pharma
RPRX
$25.3B
| $1.11M | ﹤0.01% |
26,333
-40,019
| -60% | -$1.72M |
|
|
BFS
1993
Saul Centers
BFS
$841M
| $1.11M | ﹤0.01% |
41,656
-60,153
| -59% | -$1.75M |
|
1994
CareDx
CDNA
$2.42B
| $1.1M | ﹤0.01% |
29,141
+20,115
| +223% | +$679K |
|
1995
Sphere Entertainment
SPHR
$5.73B
| $1.1M | ﹤0.01% |
16,111
| – | – |
|
1996
Donnelley Financial Solutions
DFIN
$1.16B
| $1.1M | ﹤0.01% |
82,367
-2,064
| -2% | -$21.4K |
|
|
GPMT
1997
Granite Point Mortgage Trust
GPMT
$61.2M
| $1.08M | ﹤0.01% |
152,613
+1,408
| +0.9% | +$9.49K |
|
1998
Shift4
FOUR
$3.26B
| $1.08M | ﹤0.01% |
22,343
-21,861
| -49% | -$971K |
|
1999
Opko Health
OPK
$1.02B
| $1.08M | ﹤0.01% |
292,174
+23,883
| +9% | +$101K |
|
|
TGI
2000
DELISTED
Triumph Group
TGI
| $1.07M | ﹤0.01% |
164,955
-17,864
| -10% | -$133K |
|
Similar funds
Legal & General Group's Q3 2020 Portfolio in Review
As of Q3 2020, Legal & General Group held 3,476 positions worth $224B, up 8.1% from $207B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2020: portfolio turnover was 3.2%. Legal & General Group opened 73 new positions and exited 39, leaving the 3,476-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Legal & General Group's largest Q3 2020 buy was AstraZeneca: 305,330 shares worth $33.5M.
- Legal & General Group added most to Zoom in Q3 2020, an estimated $158M increase.
- Legal & General Group's biggest Q3 2020 reduction was Apple, cutting an estimated $486M.
- Legal & General Group fully exited 58.com Inc in Q3 2020, selling an estimated $44.9M.
- Legal & General Group's ten largest holdings make up 22% of its $224B portfolio in Q3 2020.
- Legal & General Group opened 73 new positions and closed 39 in Q3 2020.
- Legal & General Group's portfolio value rose 8.1% quarter-over-quarter to $224B.
Based on Legal & General Group's 13F filing for Q3 2020, filed 13 Nov 2020.